Exposure to phthalates in neonatal intensive care unit infants: urinary concentrations of monoesters and oxidative metabolites

Jennifer Weuve, Brisa N Sánchez, Antonia M Calafat, Ted Schettler, Ronald A Green, Howard Hu, Russ Hauser, Jennifer Weuve, Brisa N Sánchez, Antonia M Calafat, Ted Schettler, Ronald A Green, Howard Hu, Russ Hauser

Abstract

Objective: We previously demonstrated that among 54 infants in neonatal intensive care units, exposure to polyvinyl chloride plastic medical devices containing the plasticizer di(2-ethylhexyl) phthalate (DEHP) is associated with urinary concentrations of mono(2-ethylhexyl) phthalate (MEHP) , a DEHP metabolite. In this follow-up report, we studied the neonates' exposure to DEHP-containing devices in relation to urinary concentrations of two other DEHP metabolites, and to urinary concentrations of metabolites of dibutyl phthalate (DBP) and benzylbutyl phthalate (BzBP) , phthalates found in construction materials and personal care products.

Measurements: A priori, we classified the intensiveness of these 54 infants' exposure to DEHP-containing medical products. We measured three metabolites of DEHP in infants' urine: MEHP and two of its oxidative metabolites, mono(2-ethyl-5-hydroxylhexyl) phthalate (MEHHP) and mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) . We also measured monobutyl phthalate (MBP) , a metabolite of DBP, and monobenzyl phthalate (MBzP), a metabolite of BzBP.

Results: Intensiveness of DEHP-containing product use was monotonically associated with all three DEHP metabolites. Urinary concentrations of MEHHP and MEOHP among infants in the high-DEHP-intensiveness group were 13-14 times the concentrations among infants in the low-intensiveness group (p</= 0.007). Concentrations of MBP were somewhat higher in the medium- and high-DEHP-intensiveness group; MBzP did not vary by product use group. Incorporating all phthalate data into a structural equation model confirmed the specific monotonic association between intensiveness of product use and biologic measures of DEHP.

Conclusion: Inclusion of the oxidative metabolites MEHHP and MEOHP strengthened the association between intensiveness of product use and biologic indices of DEHP exposure over that observed with MEHP alone.

Figures

Figure 1
Figure 1
SEM describing associations we tested among external predictors and phthalate metabolites using two latent variables. The latent variable DEHP represents exposure to DEHP, which is measured by three urinary phthalate metabolites. The latent variable DBP/BzBP represents exposure to DBP and BzBP, which is measured by urinary MBP and MBzP. Corresponding analytic results are shown in Tables 5 and 6.

References

    1. Anderson WA, Castle L, Scotter MJ, Massey RC, Springall C. A biomarker approach to measuring human dietary exposure to certain phthalate diesters. Food Addit Contam. 2001;18(12):1068–1074.
    1. ATSDR 2001. Toxicological Profile for Di-n-butyl Phthalate. Atlanta, GA:Agency for Toxic Substances and Disease Registry.
    1. ATSDR 2002. Toxicological Profile for Di(2-ethylhexyl)phthalate (DEHP). Atlanta, GA:Agency for Toxic Substances and Disease Registry.
    1. Barr DB, Silva MJ, Kato K, Reidy JA, Malek NA, Hurtz D, et al. Assessing human exposure to phthalates using monoesters and their oxidized metabolites as biomarkers. Environ Health Perspect. 2003;111:1148–1151.
    1. Becker K, Seiwert M, Angerer J, Heger W, Koch HM, Nagorka R, et al. DEHP metabolites in urine of children and DEHP in house dust. Int J Hyg Environ Health. 2004;207(5):409–417.
    1. Brock JW, Caudill SP, Silva MJ, Needham LL, Hilborn ED. Phthalate monoesters levels in the urine of young children. Bull Environ Contam Toxicol. 2002;68(3):309–314.
    1. Budtz-Jørgensen E, Keiding N, Grandjean P, Weihe P. Estimation of health effects of prenatal methylmercury exposure using structural equation models. Environ Health. 2002;1(1):2.
    1. Calafat AM, Needham LL, Silva MJ, Lambert G. Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a neonatal intensive care unit. Pediatrics. 2004;113:e429–e434.
    1. CDC 2003. Second National Report on Human Exposure to Environmental Chemicals NCEH Publ. No. 02-0716. Atlanta, GA:National Center for Environmental Health, Division of Laboratory Sciences, Centers for Disease Control and Prevention, Department of Health and Human Services.
    1. CDC 2005. Third National Report on Human Exposure to Environmental Chemicals. NCEH Publ. No. 05-0570. Atlanta, GA:Centers for Disease Control and Prevention.
    1. David RM. Exposure to phthalate esters [Letter] Environ Health Perspect. 2000;108:A440.
    1. Duty SM, Singh NP, Silva MJ, Barr DB, Brock JW, Ryan L, et al. The relationship between environmental exposures to phthalates and DNA damage in human sperm using the neutral comet assay. Environ Health Perspect. 2003;111:1164–1169.
    1. Gray TJ, Gangolli SD. Aspects of the testicular toxicity of phthalate esters. Environ Health Perspect. 1986;65:229–235.
    1. Green R, Hauser R, Calafat AM, Weuve J, Schettler T, Ringer S, et al. Use of di(2-ethylhexyl) phthalate-containing medical products and urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive care unit infants. Environ Health Perspect. 2005;113:1222–1225.
    1. Hamosh M. Lingual and gastric lipases. Nutrition. 1990;6(6):421–428.
    1. Hillman LS, Goodwin SL, Sherman WR. Identification and measurement of plasticizer in neonatal tissues after umbilical catheters and blood products. N Engl J Med. 1975;292(8):381–386.
    1. Hoppin JA, Ulmer R, London SJ. Phthalate exposure and pulmonary function. Environ Health Perspect. 2004;112:571–574.
    1. Hutson JM, Hasthorpe S, Heyns CF. Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev. 1997;18(2):259–280.
    1. Kato K, Silva MJ, Reidy JA, Hurtz D, III, Malek NA, Needham LL, et al. Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate. Environ Health Perspect. 2004;112:327–330.
    1. Kim HS, Kim TS, Shin JH, Moon HJ, Kang IH, Kim IY, et al. Neonatal exposure to di(n-butyl) phthalate (DBP) alters male reproductive-tract development. J Toxicol Environ Health A. 2004;67(23–24):2045–2060.
    1. Koch HM, Bolt HM, Angerer J. Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum after a single oral dose of deuterium-labelled DEHP. Arch Toxicol. 2004a;78(3):123–130.
    1. Koch HM, Bolt HM, Preuss R, Angerer J. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP. Arch Toxicol. 2005;79(7):367–376.
    1. Koch HM, Drexler H, Angerer J. An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population. Int J Hyg Environ Health. 2003a;206(2):77–83.
    1. Koch HM, Drexler H, Angerer J. Internal exposure of nursery-school children and their parents and teachers to di(2-ethylhexyl)phthalate (DEHP) Int J Hyg Environ Health. 2004b;207(1):15–22.
    1. Koch HM, Preuss R, Drexler H, Angerer J. Exposure of nursery school children and their parents and teachers to di-n-butylphthalate and butylbenzylphthalate. Int Arch Occup Environ Health. 2005;78(3):223–229.
    1. Koch HM, Rossbach B, Drexler H, Angerer J. Internal exposure of the general population to DEHP and other phthalates—determination of secondary and primary phthalate monoester metabolites in urine. Environ Res. 2003b;93(2):177–185.
    1. Latini G, Avery GB. Materials degradation in endotracheal tubes: a potential contributor to bronchopulmonary dysplasia. Acta Paediatr. 1999;88:1174–1175.
    1. Leeder JS, Kearns GL. Pharmacogenetics in pediatrics. Implications for practice. Pediatr Clin North Am. 1997;44(1):55–77.
    1. Lovekamp-Swan T, Davis BJ. Mechanisms of phthalate ester toxicity in the female reproductive system. Environ Health Perspect. 2003;111:139–145.
    1. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect. 2006;114:270–276.
    1. Marcel YL. Determination of di-2-ethylhexyl phthalate levels in human blood plasma and cryoprecipitates. Environ Health Perspect. 1973;3:119–121.
    1. Muthén LK. Muthén BO. 1999–2004. Mplus Users Guide. 3rd Ed. Los Angeles, CA:Muthén & Muthén.
    1. NTP-CERHR 2000a. Expert Panel Report on DEHP. Research Triangle Park, NC:National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction. Available: [accessed 15 January 2005].
    1. NTP-CERHR 2000b. Monograph on the Potential Human Reproductive and Developmental Effects of Di-n-butyl Phthalate (DBP). Research Triangle Park, NC:National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction. Available: [accessed 1 September 2005].
    1. NTP-CERHR 2003. Monograph on the Potential Human Reproductive and Developmental Effects of Butyl Benzyl Phthalate (BBP). Research Triangle Park, NC:National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction. Available: [accessed 1 September 2005].
    1. NTP-CERHR 2005. NTP-CERHR Expert Panel Updated on the Reproductive and Developmental Toxicity of Di(2-ethylhexyl) Phthalate. Research Triangle Park, NC:National Toxicology Program, Center for the Evaluation of Risks to Human Reproduction. Available: [accessed 12 December 2005].
    1. Peck CC, Albro PW. Toxic potential of the plasticizer di(2-ethylhexyl) phthalate in the context of its disposition and metabolism in primates and man. Environ Health Perspect. 1982;45:11–17.
    1. Rais-Bahrami K, Nunez S, Revenis ME, Luban NL, Short BL. Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environ Health Perspect. 2004;112:1339–1340.
    1. Rock G, Tocchi M, Ganz PR, Tackaberry ES. Incorporation of plasticizer into red cells during storage. Transfusion. 1984;24:493–498.
    1. Sánchez BN, Budtz-Jørgensen E, Ryan LM, Hu H. Structural equation models: a review with applications to environmental epidemiology. J Am Stat Assoc. 2005;100:1443–1455.
    1. Schettler T. Human exposure to phthalates via consumer products. Int J Androl. 2006;29(1):134–139.
    1. Silva MJ, Reidy JA, Preau JL, Samandar E, Needham LL, Calafat AM. Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate as biomarkers for human exposure assessment. Biomarkers. 2006;11(1):1–13.
    1. Silva MJ, Slakman AR, Reidy JA, Preau JL, Herbert AR, Samandar E, et al. Analysis of human urine for fifteen phthalate metabolites using automated solid-phase extraction. J Chromatogr B. 2004;805:161–167.
    1. Stroheker T, Cabaton N, Nourdin G, Regnier JF, Lhuguenot JC, Chagnon MC. Evaluation of anti-androgenic activity of di-(2-ethylhexyl)phthalate. Toxicology. 2005;208(1):115–121.
    1. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113:1056–1061.
    1. Tietz NW. 1990. Clinical Guide to Laboratory Tests. Philadelphia, PA:W.B. Saunders.
    1. U.S. EPA 2000. Technology Transfer Network: Bis(2-ethylhexyl) Phthalate (DEHP)—Hazard Summary. Washington, DC:U.S. Environmental Protection Agency.
    1. U.S. Food and Drug Administration 2002. Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices. Rockville, MD:U.S. Food and Drug Administration, Center for Devices and Radiological Health.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe